Loading
Telix's ready-to-label kit that lets any nuclear medicine department make the gallium PSMA scan for prostate cancer.
Illuccix was approved by the FDA in December 2021 for PET imaging of PSMA-positive lesions in men with suspected metastasis who are candidates for definitive therapy and in men with suspected recurrence based on rising PSA, and in 2025 the label was extended to selecting patients for PSMA radioligand therapy. Gozellix, a second-generation kit with longer post-labelling shelf life, was approved in 2025. Illuccix is also registered in Australia and several other markets. The kit format made PSMA PET available to centres without access to the cyclotron-produced 18F tracers.
Ball-and-stick model from PubChem 2D record (no 3D conformer available). PubChem record
Kit for on-site labelling of PSMA-11 (gozetotide) with gallium-68 from a generator or cyclotron; the tracer binds PSMA on prostate cancer cells for PET imaging. Connects to PSMA.
1.Illuccix (kit for Ga-68 gozetotide) slips into a pocket on PSMA.
| Region | Year | Indication |
|---|---|---|
| US | 2021 | PSMA PET imaging in prostate cancer (initial staging with suspected metastasis; suspected recurrence) |
| Australia | 2021 | PSMA PET imaging in prostate cancer |
| US | 2025 | Gozellix kit; selection of patients for PSMA-targeted radioligand therapy |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Illuccix" OR ABSTRACT:"Illuccix" OR TITLE:"kit for Ga-68 gozetotide" OR ABSTRACT:"kit for Ga-68 gozetotide" OR TITLE:"Gozellix" OR ABSTRACT:"Gozellix") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Illuccix (kit for Ga-68 gozetotide), not a curated reading list.
Shares Prostate cancer and the tag test.
Shares PET/CT and the tag test.
Shares Prostate cancer and the tag test.
Shares Prostate cancer and the tag test.
Shares Prostate cancer and the tag test.
Shares PSMA expression by PET (PSMA-positive), Biochemical recurrence (BCR), Theranostics, PSMA.
Shares Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial, PSMA-PreRP, PSMA, PSMA PET.
Shares Piflufolastat F-18 / Pylarify TruVu, Theranostics, Lutetium-177 vipivotide tetraxetan, PSMA.